CSGS Q1 Earnings Call: Management Highlights Diversification and Margin Expansion
Customer experience software company CSG Systems (NASDAQ:CSGS) reported Q1 CY2025 results beating Wall Street's revenue expectations , with sales up 1.5% year on year to $299.5 million. The company's full-year revenue guidance of $1.23 billion at the midpoint came in 8.1% above analysts' estimates. Its non-GAAP profit of $1.14 per share was 12% above analysts' consensus estimates.
Is now the time to buy CSGS? Find out in our full research report (it's free).
Revenue: $299.5 million vs analyst estimates of $295.2 million (1.5% year-on-year growth, 1.4% beat)
Adjusted EPS: $1.14 vs analyst estimates of $1.02 (12% beat)
Adjusted EBITDA: $64.34 million vs analyst estimates of $59.35 million (21.5% margin, 8.4% beat)
The company reconfirmed its revenue guidance for the full year of $1.23 billion at the midpoint
Management raised its full-year Adjusted EPS guidance to $4.78 at the midpoint, a 2.1% increase
EBITDA guidance for the full year is $263.5 million at the midpoint, below analyst estimates of $265 million
Operating Margin: 9.8%, in line with the same quarter last year
Market Capitalization: $1.79 billion
CSG's first quarter results reflected the company's ongoing shift toward higher-margin SaaS solutions and expanded presence in non-telecom verticals. Management noted that 33% of revenue now comes from industries outside of cable and telecom, up from 30% a year ago, which CEO Brian Shepherd described as a record for the company. Shepherd emphasized customer wins in areas like payments, healthcare, and transportation, citing extensions with Mediacom and Liberty Latin America and a new deal with the North Texas Tolling Authority as contributors to growth. These developments, alongside improved operating discipline and cost efficiencies, drove the improvement in non-GAAP operating margin compared to the prior year.
Looking forward, CSG's guidance for the remainder of the year rests on continued momentum in SaaS and recurring revenue streams, as well as disciplined cost management. Management stated that margin expansion will be fueled by a mix shift toward higher-margin SaaS deals and ongoing process improvements, with CFO Hai Tran projecting a clear path to achieve non-GAAP adjusted EBITDA margins above 25% in the coming years. Shepherd added, 'We absolutely believe there's a clear pathway for CSG to achieve at or above the upper end of our 18% to 20% non-GAAP adjusted operating margin over the next several years,' and highlighted that revenue visibility remains high due to the mission-critical nature of CSG's solutions.
Management attributed the quarter's performance to expanding into new industry verticals, a growing SaaS revenue mix, and focused cost optimization measures.
Revenue diversification progress: CSG increased its share of revenue from non-cable and non-telecom verticals to 33%, with notable wins in healthcare, financial services, and transportation. This broadening of customer base is reducing reliance on legacy telecom clients.
Large customer concentration declines: The top two customers, Charter and Comcast, now comprise 37% of total revenue, down significantly from 49% in 2017. Shepherd clarified that this is not due to declining revenue from those clients, but rather faster growth in other business areas.
SaaS margin expansion: Higher-margin SaaS product sales are driving company-wide operating leverage. CFO Hai Tran pointed to improved procurement, increased productivity, and process reengineering as key contributors to better margins.
Payments business momentum: The payments division expanded its merchant base by 13% year-over-year, reaching 135,000 merchants in the quarter, supporting both revenue growth and further diversification.
Cash flow improvement: Non-GAAP adjusted free cash flow marked its strongest first quarter result since 2018, attributed to margin gains, improved working capital, and disciplined vendor management. Management expects continued double-digit free cash flow growth as profitability scales.
CSG expects continued growth driven by SaaS adoption, recurring revenues from diversified verticals, and further operating efficiency gains.
Broadening industry exposure: Management expects further expansion into industries like healthcare, payments, and transportation to drive both top-line growth and reduced revenue concentration risk. This is supported by recent contract wins and ongoing initiatives to address complex customer needs in these sectors.
Margin expansion initiatives: The company plans to maintain or improve non-GAAP operating margins through a mix of cost discipline, greater SaaS penetration, and a shift to more asset-light operations. Shepherd pointed to continuous process optimization and targeted R&D investment as foundations for achieving margin targets.
Disciplined M&A approach: Management signaled ongoing interest in acquisitions that complement CSG's domain expertise in monetization and customer engagement, but stressed a commitment to only pursuing highly accretive, value-adding deals. The company's strong balance sheet and new revolving credit facility provide flexibility for such opportunities.
In the coming quarters, the StockStory team will be watching (1) the pace and scale of new customer wins outside of cable and telecom, (2) the degree to which SaaS solutions and payments drive further margin expansion, and (3) management's execution on disciplined M&A to support diversification. Sustained free cash flow improvement and reduced customer concentration will also be important indicators of long-term progress.
CSG currently trades at a forward P/E ratio of 13.6×. Should you double down or take your chips? Find out in our full research report (it's free).
Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.
While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
CoreWeave (CRWV) Is on Wall Street's Radar—But One Analyst Says It's a Trap
CoreWeave, Inc. (NASDAQ:) is one of the 10 AI Stocks on Wall Street's Radar. On June 10, DA Davidson analyst Gil Luria reiterated an 'Underperform' rating on CoreWeave, Inc. (NASDAQ:CRWV) with a $36.00 price target. The firm stated that CoreWeave had disclosed a pro forma contract financing structure example to analysts a day before, which indicated that shareholders will get some returns during the duration of the contracts being signed. However, it believes that the disclosure, even if accepted at face value, 'very clearly illustrates the exact opposite point.' Luria highlighted how there is no upfront equity and no returns to current equity holders during the contract. While the company assumes a 15% equity, the analyst also stated that CoreWeave does not have equity capital to invest and is instead relying on other forms of non-project debt. Such a step would require an additional $590 million, which would result in 'literally wiping out any cash they are claiming to generate for shareholders.' The firm also believes that the illustrative interest rate indicates that all of the company's previous deals are likely unprofitable. Moreover, while AI enthusiasm may likely fuel expansion, it would require the company to raise more than $10 billion in equity capital at the current share price so that it can justify the next two years of projects. This seems as the only significant upside risk to DA's analysis. While we acknowledge the potential of CRWV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
Yahoo
an hour ago
- Yahoo
Intel Corp (INTC) Shares Surge as CEO Aggressive on Turnaround Plan
We recently published a list of . In this article, we are going to take a look at where Intel Corporation (NASDAQ:INTC) stands against other top-performing companies on Tuesday. Intel Corp. extended its winning streak to a third straight day on Tuesday, adding 7.81 percent to close at $22.08 apiece as investors turned optimistic about the company's turnaround plan. Its new CEO, Lip-Bu Tan, has been working on turning Intel Corporation (NASDAQ:INTC) to profitability, with the company said to have stopped accepting new projects unless they can demonstrate a projected gross margin of at least 50 percent. Under his watch, any product projected to generate less than 50 percent gross margin will not move forward or receive engineering resources. Additionally, Tan is reportedly reviewing—and potentially cancelling or restructuring unprofitable deals with other companies. Since heading Intel Corporation (NASDAQ:INTC) earlier this year, Tan immediately restructured the company's workforce and leadership, continuing the layoff of 15,000 employees. Intel Corporation (NASDAQ:INTC) was reportedly looking to cut its workforce by 20 percent to reduce bureaucracy and refocus on engineering. A technician soldering components for a semiconductor board. In the first quarter of the year, Intel Corporation (NASDAQ:INTC) widened its attributable net loss by 115 percent to $821 million from the $381 million in the same period last year. Net revenues were flat at $12.7 billion. Overall, INTC ranks 3rd on our list of top-performing companies on Tuesday. While we acknowledge the potential of INTC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
2 hours ago
- Yahoo
Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note
Viking Therapeutics, Inc. (VKTX) closed at $28.59 in the latest trading session, marking a -1.26% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 0.38%. On the other hand, the Dow registered a gain of 0.24%, and the technology-centric Nasdaq increased by 0.24%. Prior to today's trading, shares of the company had gained 8.96% outpaced the Medical sector's gain of 4.64% and the S&P 500's gain of 6.6%. The investment community will be paying close attention to the earnings performance of Viking Therapeutics, Inc. in its upcoming release. The company is expected to report EPS of -$0.44, down 120% from the prior-year quarter. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.86 per share and revenue of $25 million, indicating changes of -84.16% and 0%, respectively, compared to the previous year. Investors should also note any recent changes to analyst estimates for Viking Therapeutics, Inc. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Right now, Viking Therapeutics, Inc. possesses a Zacks Rank of #3 (Hold). The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 74, which puts it in the top 31% of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Ensure to harness to stay updated with all these stock-shifting metrics, among others, in the next trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Viking Therapeutics, Inc. (VKTX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio